The Honolulu Liver Disease Cluster at the Medical Center: Its Mysteries and Challenges

The Honolulu Liver Disease Cluster at the Medical Center: Its Mysteries and Challenges

In 2013, physicians at the Honolulu Queen’s Medical Center (QMC) noticed that seven liver disease patients reported the use of OxyELITE Pro (OEP), a widely consumed dietary supplement (DS). Assuming a temporal association between OEP use and disease, they argued that OEP was the cause of this myster...

Full description

Bibliographic Details
Main Authors: Rolf Teschke, Axel Eickhoff
Format: Article
Language:English
Published: MDPI AG 2016-03-01
Series:International Journal of Molecular Sciences
Subjects:
Centers for Disease Control and Prevention
Food and Drug Administration
Hawaii Department of Health
Honolulu Queen’s Medical Center
OxyELITE Pro
acetaminophen
Online Access:http://www.mdpi.com/1422-0067/17/4/476

Internet

http://www.mdpi.com/1422-0067/17/4/476

Similar Items